Boudreau Philip P
EVP AND CFO
Boudreau Philip P has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.
On the most recent filing, Boudreau Philip P is listed as EVP AND CFO at ABBOTT LABORATORIES. Inside the rolling window, Boudreau Philip P reported 1 open-market purchase totaling $201K in ABT and no open-market sales.
Companies traded
Other insiders at ABT
Insider Buying
$201K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Boudreau Philip P made?
Boudreau Philip P has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Boudreau Philip P trade?
Boudreau Philip P has filed SEC Form 4 disclosures for 1 company, including ABT.
When was Boudreau Philip P's most recent SEC Form 4 filing?
Boudreau Philip P's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.
What is Boudreau Philip P's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Boudreau Philip P is listed as EVP AND CFO.
What is Boudreau Philip P's total buy and sell value in the current window?
Inside the rolling retention window, Boudreau Philip P bought $201K and sold $0 based on SEC Form 4 filings.
What was Boudreau Philip P's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 2,200 ABT shares on 2026-04-23, worth $201K, per SEC Form 4 filings.